Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antipsychotic medication |
| gptkbp:ATCCode |
N05AD09
|
| gptkbp:CASNumber |
3147-91-1
|
| gptkbp:chemicalFormula |
C15H22FN3O
|
| gptkbp:developedBy |
gptkb:Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
melperone
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedIn |
gptkb:Europe
|
| gptkbp:mechanismOfAction |
dopamine receptor antagonist
serotonin receptor antagonist |
| gptkbp:molecularWeight |
279.35 g/mol
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
weight gain
drowsiness hypotension dry mouth |
| gptkbp:synonym |
Bunilperone
Bunilperonum Melperon |
| gptkbp:usedFor |
treatment of psychosis
treatment of schizophrenia |
| gptkbp:bfsParent |
gptkb:N05CM18
|
| gptkbp:bfsLayer |
7
|